A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder.

MLA

Murru, A., et al. “A Study on the Bioequivalence of Lithium and Valproate Salivary and Blood Levels in the Treatment of Bipolar Disorder.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 27, no. 8, Aug. 2017, pp. 744–50. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2017.06.003.

APA

Murru, A., Torra, M., Callari, A., Pacchiarotti, I., Romero, S., Gonzalez de la Presa, B., Varo, C., Goikolea, J. M., Pérez-Sola, V., Vieta, E., & Colom, F. (2017). A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 27(8), 744–750. https://doi.org/10.1016/j.euroneuro.2017.06.003

Chicago

Murru, A, M Torra, A Callari, I Pacchiarotti, S Romero, B Gonzalez de la Presa, C Varo, et al. 2017. “A Study on the Bioequivalence of Lithium and Valproate Salivary and Blood Levels in the Treatment of Bipolar Disorder.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 27 (8): 744–50. doi:10.1016/j.euroneuro.2017.06.003.